Summary:
- The FDA has approved the world's first and only injectable HIV prevention medication that only needs to be administered twice a year.
- This new treatment, called Apretude, is a long-acting injectable form of the HIV prevention drug cabotegravir, which was previously only available as a daily oral pill.
- The twice-yearly injection can provide continuous HIV prevention for people at high risk of contracting the virus, potentially improving adherence and reducing the burden of daily medication.